Financial Daily from THE HINDU group of publications
Tuesday, September 13, 2005
Markets (Sept 12)
BL 2502456.45 (+29.97)
BSE Sensex8138.42 (+78.41)
S&P CNX Nifty2484.15 (+28.70)
US Dollar (Buy/Sell)43.79/43.92
Gold Std (10 gm)6435 (+5)

Port Info


Group Sites


Bharti-Changi pulls out of airport project
THE Government's ambitious programme for modernisation and restructuring of Delhi and Mumbai airports has run into a rough patch. On Monday, one of the bidders, the Bharti Group expressed its inability to participate in the project because its ... More

Bandwidth rates in India among highest — TRAI justifies price regulation
The move has been opposed by VSNL, which controls nearly 80 per cent of the bandwidth market. More

Sensex climb continues, touches 8,138
IT was the seventh consecutive day of record high and ninth day of rise for the stock markets on Monday. Continued buying by institutional investors, foreign and domestic, and expectation of sound corporate earnings season ahead contributed to ... More

JP Morgan in talks to buy stake in Andhra Cements
JP Morgan is in talks with Mr G.P. Goenka for picking up approximately 15 per cent stake in Andhra Cements Ltd, the ailing cement producer. JP Morgan is aiming at precisely 14.95 per cent of the company's equity, sources close to the ... More

Negative growth in electricity, mining pulls down IIP in July
NEGATIVE growth in the electricity and mining sectors in July this year lowered the overall growth in industrial production to 6.7 per cent against 8.5 per cent in July 2004, according to an official release. On a cumulative basis, however, the ... More

Home textiles - the next big opportunity
AFTER garments, home furnishing is emerging as the next hot destination for textile players. Exports of home textiles - bed, bath and kitchen linen - have zoomed over the past six months, after the dismantling of quotas, sparking off a ... More

Ranbaxy guns for Pfizer's $12-b cholesterol drug — Generic cos watch blockbuster battle closely
IT is the mother of all patent challenges, quips an analyst closely watching the development of Ranbaxy's onslaught on Pfizer's $12-billion cholesterol drug Lipitor. Whether or not success is scripted in favour of Ranbaxy, the case is becoming ... More

Comments & Letters to the Editor to:
Subscribe to: Business Line
Banknet India

Tata Safari Dicor

Punjab National Bank

The Hindu Images

Road Less Travel

Sportstar eBook

Pick a Winner Stock Market Contest

Top Stories
Power Ministry may drop plans to clip regulators' wings

The myth of a global savings glut

RBI's Annual Report 2004-05 — Pervading optimism, major concerns

Plan to identify `weak' private banks dropped

Pvt TV channels must pay for Prasar Bharati's DTH platform

SMEs to propel growth in security tool market: IDC

Coffee Board sees exports rising in Jan-March

In Focus

BHEL Disinvestment
The Yuan Revaluation
Dabhol power regenerated
Tracking the rains
Sethusamudram Canal Project
India Inc's overseas acquisition

In Depth

Gender Justice
Simple Economics
Tax Talk

The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright 2005, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line